肝硬化门静脉血栓形成的治疗：仍是一个未解决的问题。 - Suppr

Suppr

超能文献

Treatment of portal vein thrombosis in cirrhosis: still an open issue.

作者信息

Mancuso Andrea

机构信息

Medicina Interna 1, ARNAS Civico - Di Cristina - Benfratelli, Piazzale Leotta 4, 90100, Palermo, Italy.

出版信息

Hepatol Int. 2025 Feb;19(1):259-260. doi: 10.1007/s12072-024-10759-2. Epub 2024 Dec 11.

DOI:10.1007/s12072-024-10759-2

PMID:39663348

Abstract

摘要

相似文献

Treatment of portal vein thrombosis in cirrhosis: still an open issue.肝硬化门静脉血栓形成的治疗：仍是一个未解决的问题。

Hepatol Int. 2025 Feb;19(1):259-260. doi: 10.1007/s12072-024-10759-2. Epub 2024 Dec 11.

Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry.门静脉血栓形成与肝硬化的相关性：意大利静脉血栓形成事件登记处

Intern Emerg Med. 2016 Dec;11(8):1059-1066. doi: 10.1007/s11739-016-1416-8. Epub 2016 Mar 30.

[Complexities and challenges in the management of portal vein thrombosis in cirrhosis].[肝硬化门静脉血栓形成管理中的复杂性与挑战]

Zhonghua Gan Zang Bing Za Zhi. 2021 Mar 20;29(3):196-198. doi: 10.3760/cma.j.cn501113-20210127-00046.

Systematic review: portal vein thrombosis in cirrhosis.系统评价：肝硬化门静脉血栓形成。

Aliment Pharmacol Ther. 2010 Feb 1;31(3):366-74. doi: 10.1111/j.1365-2036.2009.04182.x. Epub 2009 Oct 23.

[Impact of portal vein thrombosis on the efficacy of endoscopic treatment in preventing re-bleeding from ruptured gastroesophageal varices in hepatitis B-related liver cirrhosis].[门静脉血栓形成对乙型肝炎相关肝硬化患者食管胃静脉曲张破裂出血内镜治疗预防再出血疗效的影响]

Zhonghua Gan Zang Bing Za Zhi. 2020 Sep 20;28(9):747-752. doi: 10.3760/cma.j.cn501113-20200616-00326.

Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review.肝硬化背景下的门静脉血栓形成：全面综述

J Clin Med. 2022 Oct 30;11(21):6435. doi: 10.3390/jcm11216435.

The risk factors of liver cirrhosis complicated with portal vein thrombosis and the efficacy and safety of anticoagulant therapy: a meta analysis.肝硬化合并门静脉血栓形成的危险因素及抗凝治疗的疗效与安全性：一项荟萃分析

Thromb J. 2025 May 2;23(1):43. doi: 10.1186/s12959-025-00725-9.

Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.抗凝治疗可改善肝硬化合并门静脉血栓形成患者的生存率：IMPORTAL 竞争风险荟萃分析。

J Hepatol. 2023 Jul;79(1):69-78. doi: 10.1016/j.jhep.2023.02.023. Epub 2023 Feb 28.

Risk Factors for Portal Vein Thrombosis in Patients With Cirrhosis Awaiting Liver Transplantation in Shiraz, Iran.伊朗设拉子等待肝移植的肝硬化患者门静脉血栓形成的危险因素

Hepat Mon. 2015 Dec 27;15(12):e26407. doi: 10.5812/hepatmon.26407. eCollection 2015 Dec.

Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis.肝硬化与非肝硬化患者门静脉血栓形成的诊断、发展和治疗。

Gastroenterology. 2019 May;156(6):1582-1599.e1. doi: 10.1053/j.gastro.2019.01.265. Epub 2019 Feb 13.

本文引用的文献

In response to "Key considerations in portal vein thrombosis management".针对《门静脉血栓形成管理中的关键考虑因素》

Hepatol Int. 2025 Feb;19(1):258. doi: 10.1007/s12072-024-10747-6. Epub 2024 Nov 15.

Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus.肝硬化患者的非恶性门静脉血栓由内膜纤维化伴有或不伴有富含纤维蛋白的血栓组成。

Hepatology. 2022 Apr;75(4):898-911. doi: 10.1002/hep.32169. Epub 2021 Dec 5.

Transient portal vein thrombosis in liver cirrhosis.肝硬化时的门静脉血栓形成。

BMC Med. 2018 Jun 5;16(1):83. doi: 10.1186/s12916-018-1069-8.

Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.肝硬化合并门静脉血栓形成患者抗凝治疗的效果：系统评价和荟萃分析。

Gastroenterology. 2017 Aug;153(2):480-487.e1. doi: 10.1053/j.gastro.2017.04.042. Epub 2017 May 4.

Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study.1,243 例肝硬化患者门静脉血栓形成的病因和后果：一项纵向研究的结果。

Hepatology. 2015 Feb;61(2):660-7. doi: 10.1002/hep.27546. Epub 2015 Jan 5.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验